文献速递骨质疏松与代谢性骨病创伤骨科

COL1A2基因新突变与短暂性区域性骨质疏松相关

A novel mutation in collagen gene COL1A2 associated with transient regional osteoporosis.
PubMed 文献 · Osteoporos Int · 2021-08-31

本文报告一名25岁白人男性短暂性区域性骨质疏松(TRO)病例,基因分析发现COL1A2基因新发杂合错义变异c.488G>A(p.Gly163Asp),预测为可能致病。作者提出TRO可能是成骨不全症因骨量减少和骨小梁力学性能受损的一种临床表现。

要点

  • TRO患者应警惕潜在遗传性骨脆性疾病如成骨不全症。
  • COL1A2新发变异c.488G>A可能通过损害骨小梁力学性能诱发微骨折。
  • 反复症状性骨髓水肿可能是遗传性结缔组织病骨脆性的临床表现。

核心结论

  • COL1A2基因新发杂合错义变异c.488G>A可能诱导骨小梁微骨折倾向,反复症状性骨髓水肿表现与遗传性结缔组织病致骨脆性假说一致。

研究设计与样本

  • 病例报告:一名25岁白人男性TRO患者,采集病史及家族史,进行生化、MRI和DXA评估,并对COL1A1、COL1A2、COL2A1、CASR、CYP19A1、CUL7、CRTAP、KAL1、LEPRE1、LRP5、PPIB和SLC9A3R1基因行下一代测序。

主要发现

  • 鉴定出COL1A2基因(NM_000089.3)第11外显子新发杂合错义变异c.488G>A,导致I型胶原螺旋结构域N端 putative p.Gly163Asp替换。
  • 该变异经计算机预测工具预测为有害,分类为可能致病。
  • 该突变可影响骨骼健康,损害骨量和骨小梁力学性能,诱发特征酷似TRO的疾病。

临床怎么用

  • 对TRO患者,尤其伴轻度成骨不全症临床线索时,可考虑行COL1A2等相关基因检测以明确遗传基础。

局限性

  • 本文为单例病例报告,因果关联需进一步功能研究和更大样本验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: A young man was diagnosed with transient regional osteoporosis (TRO). The genetic analysis revealed a novel de novo likely pathogenic variant in COL1A2 gene. Our hypothesis is that TRO may be a possible clinical manifestation of osteogenesis imperfecta due to a reduced bone mass and an impaired trabecular mechanical competence. INTRODUCTION: Transient regional osteoporosis (TRO) is a disease characterized by episodes of pain in the lower limbs involving the hip, knee, ankle or foot. Here, we present a clinical case of a Caucasian 25-year-old man exhibiting TRO. Based on few mild clinical findings suggestive of osteogenesis imperfecta (OI), but without a history of fragility fractures, we performed a genetic assessment to investigate this hypothesis. METHODS: Medical history was obtained from the patient and family members, including biochemical, RMI and DXA assessments. Next-generation sequencing of COL1A1, COL1A2, COL2A1, CASR, CYP19A1, CUL7, CRTAP, KAL1, LEPRE1, LRP5, PPIB and SLC9A3R1, genes involved in juvenile osteoporosis, was performed. RESULTS: We identified a novel de novo heterozygous missense variant, c.488G > A, in exon 11 of the COL1A2 gene (NM_000089.3), resulting in the putative p.Gly163Asp substitution in the N-terminal part of the helical domain of type I collagen. The variant was predicted to be damaging by the in silico prediction tools and the mutation was therefore classified as likely pathogenic. This mutation can affect skeletal health impairing bone mass and trabecular mechanical competence, inducing a disease whose features strictly evoke a TRO. CONCLUSION: The present study describes a novel de novo heterozygous missense variant in COL1A2 gene, possibly inducing a propensity to trabecular microfractures. The recurrent symptomatic bone marrow oedema episodes could be the clinical picture consistent with the hypothesis of an inherited connective tissue disorder giving bone fragility.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Varenna M, Crotti C, Bonati MT, et al. A novel mutation in collagen gene COL1A2 associated with transient regional osteoporosis. Osteoporos Int. 2021. PMID: 34463844. doi:10.1007/s00198-021-06135-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。